QDELZIQ Trademark

Trademark Overview

On Tuesday, May 17, 2022, a trademark application was filed for QDELZIQ with the United States Patent and Trademark Office. The USPTO has given the QDELZIQ trademark a serial number of 97415111. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Thursday, June 6, 2024. This trademark is owned by CymaBay Therapeutics, Inc.. The QDELZIQ trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of liver diseases
qdelziq

General Information

Serial Number97415111
Word MarkQDELZIQ
Filing DateTuesday, May 17, 2022
Status731 - SECOND EXTENSION - GRANTED
Status DateThursday, June 6, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 11, 2023

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of liver diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, May 24, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCymaBay Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNewark, CA 94560
Party NameCymaBay Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNewark, CA 94560

Trademark Events

Event DateEvent Description
Friday, May 20, 2022NEW APPLICATION ENTERED
Tuesday, May 24, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 6, 2023ASSIGNED TO EXAMINER
Tuesday, March 7, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 22, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 11, 2023PUBLISHED FOR OPPOSITION
Tuesday, April 11, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 6, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, November 10, 2023SOU TEAS EXTENSION RECEIVED
Friday, November 10, 2023SOU EXTENSION 1 FILED
Friday, November 10, 2023SOU EXTENSION 1 GRANTED
Tuesday, November 14, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 5, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, June 5, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, June 5, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, June 5, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, June 5, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, June 5, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, June 6, 2024SOU TEAS EXTENSION RECEIVED
Thursday, June 6, 2024SOU EXTENSION 2 FILED
Thursday, June 6, 2024SOU EXTENSION 2 GRANTED
Thursday, June 13, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

qdelziq liver diseases treatment substances preparations pharmaceutical